Core Insights - Ginkgo Bioworks has been selected by the Environmental Molecular Sciences Laboratory (EMSL) to deliver an automated anaerobic phenotyping platform, marking a significant advancement in biological research and bioeconomy leadership [1][6] - The contract, valued at $4.66 million, involves constructing a fully integrated workcell with 18 devices within a modular anaerobic chamber, designed to enhance laboratory efficiency and data quality [3][4] - Ginkgo Automation's Reconfigurable Automation Cart (RAC) technology will enable remote operation of complex workflows, streamlining research processes and accelerating discovery in microbial engineering and biodesign [4][5] Company Overview - Ginkgo Bioworks focuses on making biology easier to engineer, providing customizable R&D solutions across therapeutics, diagnostics, and manufacturing [7] - The company offers modular laboratory automation systems that allow scientists to focus on planning and analyzing experiments rather than manual tasks [7] - Ginkgo's automation technology has been deployed in various labs, resulting in increased throughput, repeatability, and reduced cycle times [5][6]